See more.
Know more.
Discover LUMICKS
We are LUMICKS
LUMICKS is a next-generation life science tools company focused on enabling more efficient research, drug development, bioprocessing, bioproduction quality control, and patient treatment. For the first time ever, our unparalleled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.
Our mission
Empowering academic & pharmaceutical communities
We empower the academic and pharmaceutical communities with cutting-edge technologies to deeply understand the mechanisms of life and disease, driving the discovery and development of life-saving therapies
Our history
Learn about what got us here, and what’s keeping us going.
One LUMICKS
2022 - Now
We successfully navigated through a pandemic which greatly affected biotechs worldwide. In these new times, we are focusing on optimizing and efficiency.
Entering new markets
2018 - 2021
We greatly improved our C-Trap platform, which continued to empower researches with many publications in key journals. With Cell Avidity and the z-Movi we launched into immuno-oncology markets, and saw immediate impact through installations at biotech companies. With $93m in Series D funding we grew to ~250 FTE and moved offices to enable to grow further. We expanded offices in Beijing to further serve the APR market.
Breaking through
2015 - 2017
A fast few years that saw us grow to over 38 employees and make key sales to Rockefeller, ShanghaiTech and Max Planck Institute. We saw our users publish in Nature magazine. Internally we developed acoustic force spectroscopy technology and ran a collaborative project with a leading pharmaceutical. Our Boston office was opened and we secured Series A funding.
Early years
2013 - 2014
A first patent filed and a first module sold to Harvard. LUMICKS was officially founded.
How far we’ve come
Achievements
We are an international team exceeding 150 people with more than 30 nationalities. We are proud of our great sense of ownership with the mentality of being open-minded in teamwork. We embrace challenges and maximize opportunity and experience.
200+
Systems installed across the globe
150+
People
230+
Publications by our users
10.5
Average impact factor in journals
Our management team
An experienced group combining business and technical expertise
Hugo de Wit
Chief Executive Officer
Hugo leads LUMICKS as CEO with over 30 years of experience scaling life science ventures, from startups to multinationals. Formerly heading Cell Culture Technologies at Sartorius, he also held roles at Lonza, Merck, Siegfried, and PanGenetics. With an MSc and Executive MBA, Hugo steers LUMICKS’ strategic vision and global growth.
Andrea Candelli, PhD
Chief Scientific Officer & Head of Marketing
Andrea co-founded LUMICKS, holds a PhD in Physics, and co-invented its core technologies. As Chief Scientific Officer and Head of Marketing, Andrea leads the company’s science and technology vision, fosters scientific collaborations, crafts marketing strategies, and integrates pioneering research with brand outreach to expand LUMICKS’ impact in advanced life science research.
Gerrit Sitters, PhD
Director of Product Management
Gerrit co-founded LUMICKS and co-invented the core LUMICKS technologies. As Director of Product Management, he aligns product development roadmaps with market and customer needs, ensuring LUMICKS’ solutions address critical gaps in life science and pharmaceutical research. Gerrit fosters collaboration to drive innovation across the LUMICKS product portfolio.
Gijs Oude Elberink
Chief Operating Officer
Gijs serves as Chief Operating Officer, leveraging leadership experience at Philips and Thermo Fisher Scientific. He oversees supply chain, logistics, service, and operations, ensuring smooth processes that support LUMICKS’ growth. Known for streamlining production in high-tech environments, Gijs empowers cross-functional teams to deliver pioneering solutions across global life science markets.
Edmee Verhulp
Chief Financial Officer
Edmee is Chief Financial Officer, drawing on a tech-focused background in biotechnology, business economics, and valuation. She orchestrated key acquisitions, including Bluebee’s sale to Illumina, and advised multiple high-growth ventures. At LUMICKS, Edmee oversees financial strategy and resource allocation, ensuring innovation can flourish while driving sustainable expansion in global markets.
Michael Savage
Corporate Business Development
Michael advances LUMICKS’ corporate business development strategy, leveraging global account leadership experience from PerkinElmer and Agilent. He drives scientific partnerships, go-to-market execution, and product positioning for emerging applications. Michael’s initiatives expand LUMICKS’ reach in developing markets, enabling deeper engagement with worldwide leading researchers and clinicians
Jochum de Graaf
Sales Director
Jochum is Sales Director, bringing a proven track record in life science instrument sales from Merck and Unchained Labs. At LUMICKS, he drives the expansion of the global commercial footprint and establishes rigorous sales processes across geographies, products and teams. Jochum’s leadership accelerates global adoption of LUMICKS’ advanced technologies in academic and pharmaceutical markets.
Freek Blom, PhD
R&D Director
Freek leads LUMICKS’ multidisciplinary R&D team and oversees its strategic direction. As Director of Research & Development, he is responsible for product innovation and development from concept to production. With more than 25-years technical experience ranging from development engineer to Vice President R&D at Sonion, Freek enables and develops the quality of our products as well as the teams that make them happen.
Hannah van Drunen
HR Director
Hannah serves as HR Director, supporting global teams across operations, commercial, marketing and R&D. She fosters an environment where employees thrive, driving organisational design, alignment and culture. Drawing on extensive HR experience from Ahold and Bunq, Hannah ensures people strategies accelerate growth, empowering LUMICKS employees to deliver transformative solutions worldwide.
Our board of directors
Seasoned business & life science experts advising us on strategy and key decisions
Scientific advisors
The most knowledgeable people on our applications and technology
Life at LUMICKS
The people making it happen
We are an international team exceeding 150 people with more than 30 nationalities. We are proud of our great sense of ownership with the mentality of being open-minded in teamwork. We embrace challenges and maximize opportunity and experience.
See more. Know more.
We empower the academic and pharmaceutical communities with cutting-edge technologies to deeply understand the mechanisms of life and disease, driving the discovery and development of life-saving therapies
All products and technologies are for Research Use Only (RUO) except when specifically noted